Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$27.44 - $35.56 $683,887 - $886,261
-24,923 Reduced 39.28%
38,532 $1.13 Million
Q4 2023

Feb 14, 2024

SELL
$28.47 - $38.49 $1.84 Million - $2.49 Million
-64,793 Reduced 50.52%
63,455 $2.31 Million
Q3 2023

Nov 14, 2023

SELL
$28.28 - $38.36 $1.63 Million - $2.22 Million
-57,759 Reduced 31.05%
128,248 $4.12 Million
Q2 2023

Aug 11, 2023

SELL
$17.67 - $31.31 $270,085 - $478,573
-15,285 Reduced 7.59%
186,007 $5.82 Million
Q1 2023

May 16, 2023

BUY
$17.13 - $38.52 $3.45 Million - $7.75 Million
201,292 New
201,292 $4.59 Million
Q3 2021

Nov 15, 2021

SELL
$52.8 - $60.32 $430,900 - $492,271
-8,161 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$51.29 - $59.15 $76,063 - $87,719
1,483 Added 22.21%
8,161 $443,000
Q1 2021

May 17, 2021

BUY
$42.18 - $56.07 $53,020 - $70,479
1,257 Added 23.19%
6,678 $374,000
Q4 2020

Feb 16, 2021

SELL
$35.18 - $43.52 $20,932 - $25,894
-595 Reduced 9.89%
5,421 $236,000
Q3 2020

Nov 16, 2020

BUY
$37.98 - $48.72 $228,487 - $293,099
6,016 New
6,016 $234,000
Q1 2020

May 15, 2020

SELL
$22.46 - $42.24 $357,518 - $672,376
-15,918 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$39.01 - $47.51 $802,981 - $977,945
-20,584 Reduced 56.39%
15,918 $659,000
Q3 2019

Nov 14, 2019

SELL
$38.66 - $47.41 $3.01 Million - $3.69 Million
-77,751 Reduced 68.05%
36,502 $1.67 Million
Q2 2019

Aug 16, 2019

BUY
$38.23 - $47.43 $232,361 - $288,279
6,078 Added 5.62%
114,253 $4.93 Million
Q2 2019

Aug 14, 2019

BUY
$38.23 - $47.43 $3.9 Million - $4.84 Million
101,991 Added 1649.27%
108,175 $4.67 Million
Q4 2018

Feb 14, 2019

SELL
$44.93 - $73.38 $302,019 - $493,260
-6,722 Reduced 52.08%
6,184 $292,000
Q3 2018

Nov 14, 2018

BUY
$56.85 - $80.35 $489,478 - $691,813
8,610 Added 200.42%
12,906 $963,000
Q2 2018

Aug 14, 2018

BUY
$35.85 - $57.05 $154,011 - $245,086
4,296 New
4,296 $237,000

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $539M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.